Masao Hagihara Yui Imai Tomoyuki Uchida Shin Ohara Morihiro Inoue Tomiyuki Sugi Keiko Mitamura
10.2169/internalmedicine.9513-22
Intern Med
2022;61(14):2215-2219.
sars-cov-2 anti-spike igg bendamustine cellular immunity prolonged infection vaccine
CC BY-NC-ND
https://pubmed.ncbi.nlm.nih.gov/35850990/
COVID-19 Lymphoma Viral Vaccines
COVID-19 Lymphoma Viral Vaccines Case Reports Adult Antibodies, Viral BNT162 Vaccine Humans Male Middle Aged SARS-CoV-2 Vaccination Antibodies, Viral Viral Vaccines BNT162 Vaccine
PMC9381351
35850990
Successful Elimination of SARS-CoV-2 Following Vaccination with BNT162b2 after Prolonged Viral Infection in an Immunocompromised Lymphoma Patient
2022